193 related articles for article (PubMed ID: 23189934)
21. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
23. BCL2 mutations in diffuse large B-cell lymphoma.
Schuetz JM; Johnson NA; Morin RD; Scott DW; Tan K; Ben-Nierah S; Boyle M; Slack GW; Marra MA; Connors JM; Brooks-Wilson AR; Gascoyne RD
Leukemia; 2012 Jun; 26(6):1383-90. PubMed ID: 22189900
[TBL] [Abstract][Full Text] [Related]
24. Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.
Czuchlewski DR; Csernus B; Bubman D; Hyjek E; Martin P; Chadburn A; Knowles DM; Cesarman E
Am J Clin Pathol; 2008 Dec; 130(6):957-62. PubMed ID: 19019774
[TBL] [Abstract][Full Text] [Related]
25. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
[TBL] [Abstract][Full Text] [Related]
26. High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.
Moore AM; Moshkin O; Swain GJ; Crocker S; LeBrun DP
Diagn Pathol; 2018 May; 13(1):34. PubMed ID: 29793519
[TBL] [Abstract][Full Text] [Related]
27. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
28. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
Jardin F; Buchonnet G; Parmentier F; Contentin N; Leprêtre S; Lenain P; Picquenot JM; Laberge S; Bertrand P; Stamatoullas A; D'Anjou J; Tilly H; Bastard C
Leukemia; 2002 Nov; 16(11):2318-25. PubMed ID: 12399978
[TBL] [Abstract][Full Text] [Related]
29. The significance of FOXP1 in diffuse large B-cell lymphoma.
Gascoyne DM; Banham AH
Leuk Lymphoma; 2017 May; 58(5):1037-1051. PubMed ID: 27678023
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.
Chen J; Xu-Monette ZY; Deng L; Shen Q; Manyam GC; Martinez-Lopez A; Zhang L; Montes-Moreno S; Visco C; Tzankov A; Yin L; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Pham L; Young KH
Oncotarget; 2015 Mar; 6(8):5597-614. PubMed ID: 25704881
[TBL] [Abstract][Full Text] [Related]
31. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
32. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
33. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
34. FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
Wong KK; Gascoyne DM; Soilleux EJ; Lyne L; Spearman H; Roncador G; Pedersen LM; Møller MB; Green TM; Banham AH
Oncotarget; 2016 Aug; 7(33):52940-52956. PubMed ID: 27224915
[TBL] [Abstract][Full Text] [Related]
35. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
[No Abstract] [Full Text] [Related]
36. Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.
Maesako Y; Uchiyama T; Ohno H
Cancer Sci; 2003 Sep; 94(9):774-81. PubMed ID: 12967475
[TBL] [Abstract][Full Text] [Related]
37. Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Uhl B; Prochazka KT; Pansy K; Wenzl K; Strobl J; Baumgartner C; Szmyra MM; Waha JE; Wolf A; Tomazic PV; Steinbauer E; Steinwender M; Friedl S; Weniger M; Küppers R; Pichler M; Greinix HT; Stary G; Ramsay AG; Apollonio B; Feichtinger J; Beham-Schmid C; Neumeister P; Deutsch AJ
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887224
[TBL] [Abstract][Full Text] [Related]
38. FilGAP, a Rac-specific Rho GTPase-activating protein, is a novel prognostic factor for follicular lymphoma.
Nishi T; Takahashi H; Hashimura M; Yoshida T; Ohta Y; Saegusa M
Cancer Med; 2015 Jun; 4(6):808-18. PubMed ID: 25641953
[TBL] [Abstract][Full Text] [Related]
39. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
40. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]